Virtual Library

Start Your Search

Jiangping Xiong



Author of

  • +

    P1.03 - Chemotherapy/Targeted Therapy (ID 689)

    • Event: WCLC 2017
    • Type: Poster Session with Presenters Present
    • Track: Chemotherapy/Targeted Therapy
    • Presentations: 1
    • +

      P1.03-019 - Sophoridine Inhibits Lung Cancer Cell Proliferation through Activating Hippo Signaling and P53 Pathway (ID 8046)

      09:30 - 16:00  |  Presenting Author(s): Jiangping Xiong

      • Abstract
      • Slides

      Background:
      Lung cancer is regarded as the most commonly diagnosed malignant disease with the leading cause of cancer-associated death. Sophoridine is a quinolizidine alkaloid extracted from Sophora alopecuroides L, a traditional Chinese medicine, which was found to have diverse pharmacological properties such as anti-inflammatory and anti-cancer. In our current research, we evaluated the effect of sophoridine alone and in combination with cisplatin on various human lung cancer cell lines and also explored the possible anti-cancer mechanisms underlie.

      Method:
      Colony formation assay, CCK-8 assay as well as transwell invasion and migration assay were adopted to investigate the anti-cancer effects of Sophoridine through a series of human lung cancer cell lines. Western-blot and Quantitative Real-time PCR were used to explore the possible underlying mechanisms of the inhibitory effect of Sophoridine on lung cancer progress.

      Result:
      We confirmed that Sophoridine can inhibit lung cancer cell proliferation, invasion and migration significantly. In addition, the Hippo-YAP pathway and p53 signaling might be involved in the inhibitory effect of Sophoridine in NCI-H446, NCI-H460 and A549 cell lines but not in the p53-deficient NCI-H1299 cells. Quantitative Real-time PCR showed that Sophoridine can dramatically suppress the downstream targets of Hippo-YAP1 pathway such as CYR61, CDX2, FOXM1, c-Myc and VEGF.

      Conclusion:
      In conclusion, our study first suggested that sophoridine might be used as a novel agent for lung cancer.

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.